APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Imaging Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cancer Imaging Software Market Outlook and Growth Opportunities 2026

12 August 2026193 pages

Choose your research edition.

Industry ResearchCancer Imaging Software Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Imaging Software Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cancer Imaging Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Imaging Software Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Imaging Software Market Analysis and Forecast 2026-2032170 pages · $4,950 USD

Market perspective

The global Cancer Imaging Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cancer Imaging Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cancer Imaging Software market include Imaris, Varian, DOSIsoft, Certis Oncology, MIM Software Inc., Arterys, SIEMENS, Brainomix and Oncology Systems Limited, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cancer Imaging Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Imaging Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Imaging Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cancer Imaging Software market.

Cancer Imaging Software Segment by Company

Imaris

Varian

DOSIsoft

Certis Oncology

MIM Software Inc.

Arterys

SIEMENS

Brainomix

Oncology Systems Limited

Mirada

GE HealthCare

Mint Medical

Cancer Imaging Software Segment by Type

CT

MRI

MRA

Others

Cancer Imaging Software Segment by Application

Clinical Routine

Clinical Trials

Cancer Imaging Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cancer Imaging Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cancer Imaging Software key companies, revenue, market share, and recent developments.

3. To split the Cancer Imaging Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cancer Imaging Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cancer Imaging Software significant trends, drivers, influence factors in global and regions.

6. To analyze Cancer Imaging Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Imaging Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cancer Imaging Software industry.

Chapter 3: Detailed analysis of Cancer Imaging Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cancer Imaging Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cancer Imaging Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cancer Imaging Software Industry Trends Table 2. Cancer Imaging Software Industry Drivers Table 3. Cancer Imaging Software Industry Opportunities and Challenges Table 4. Cancer Imaging Software Industry Restraints Table 5. Global Cancer Imaging Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cancer Imaging Software Revenue Share by Company (2021-2026) Table 7. Global Cancer Imaging Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cancer Imaging Software Key Company Manufacturing Base & Headquarters Table 9. Global Cancer Imaging Software Company, Product Type & Application Table 10. Global Cancer Imaging Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cancer Imaging Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of CT Table 15. Significant Companies of MRI Table 16. Significant Companies of MRA Table 17. Significant Companies of Others Table 18. Global Cancer Imaging Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Cancer Imaging Software Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Cancer Imaging Software Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Cancer Imaging Software Sales Value Share by Type (2021-2026) Table 22. Global Cancer Imaging Software Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Clinical Routine Table 24. Significant Companies of Clinical Trials Table 25. Global Cancer Imaging Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cancer Imaging Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cancer Imaging Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cancer Imaging Software Sales Value Share by Application (2021-2026) Table 29. Global Cancer Imaging Software Sales Value Share by Application (2027-2032) Table 30. Global Cancer Imaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cancer Imaging Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cancer Imaging Software Sales Value Share by Region (2021-2026) Table 33. Global Cancer Imaging Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cancer Imaging Software Sales Value Share by Region (2027-2032) Table 35. Global Cancer Imaging Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cancer Imaging Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cancer Imaging Software Sales Value Market Share by Country (2021-2026) Table 38. Global Cancer Imaging Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cancer Imaging Software Sales Value Market Share by Country (2027-2032) Table 40. Imaris Company Information Table 41. Imaris Business Overview Table 42. Imaris Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Imaris Cancer Imaging Software Product Portfolio Table 44. Imaris Recent Development Table 45. Varian Company Information Table 46. Varian Business Overview Table 47. Varian Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Varian Cancer Imaging Software Product Portfolio Table 49. Varian Recent Development Table 50. DOSIsoft Company Information Table 51. DOSIsoft Business Overview Table 52. DOSIsoft Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. DOSIsoft Cancer Imaging Software Product Portfolio Table 54. DOSIsoft Recent Development Table 55. Certis Oncology Company Information Table 56. Certis Oncology Business Overview Table 57. Certis Oncology Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Certis Oncology Cancer Imaging Software Product Portfolio Table 59. Certis Oncology Recent Development Table 60. MIM Software Inc. Company Information Table 61. MIM Software Inc. Business Overview Table 62. MIM Software Inc. Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MIM Software Inc. Cancer Imaging Software Product Portfolio Table 64. MIM Software Inc. Recent Development Table 65. Arterys Company Information Table 66. Arterys Business Overview Table 67. Arterys Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Arterys Cancer Imaging Software Product Portfolio Table 69. Arterys Recent Development Table 70. SIEMENS Company Information Table 71. SIEMENS Business Overview Table 72. SIEMENS Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. SIEMENS Cancer Imaging Software Product Portfolio Table 74. SIEMENS Recent Development Table 75. Brainomix Company Information Table 76. Brainomix Business Overview Table 77. Brainomix Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Brainomix Cancer Imaging Software Product Portfolio Table 79. Brainomix Recent Development Table 80. Oncology Systems Limited Company Information Table 81. Oncology Systems Limited Business Overview Table 82. Oncology Systems Limited Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Oncology Systems Limited Cancer Imaging Software Product Portfolio Table 84. Oncology Systems Limited Recent Development Table 85. Mirada Company Information Table 86. Mirada Business Overview Table 87. Mirada Cancer Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Mirada Cancer Imaging Software Product Portfolio Table 89. Mirada Recent Development Table 90. GE HealthCare Company Information Table 91. GE HealthCare Business Overview Table 92. GE HealthCare Cancer Imaging Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. GE HealthCare Cancer Imaging Software Product Portfolio Table 94. GE HealthCare Recent Development Table 95. Mint Medical Company Information Table 96. Mint Medical Business Overview Table 97. Mint Medical Cancer Imaging Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Mint Medical Cancer Imaging Software Product Portfolio Table 99. Mint Medical Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Cancer Imaging Software Product Image Figure 2. Global Cancer Imaging Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Imaging Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Imaging Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. CT Image Figure 8. MRI Image Figure 9. MRA Image Figure 10. Others Image Figure 11. Global Cancer Imaging Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Cancer Imaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Cancer Imaging Software Sales Value Share by Type (2021-2032) Figure 14. Clinical Routine Image Figure 15. Clinical Trials Image Figure 16. Global Cancer Imaging Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cancer Imaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cancer Imaging Software Sales Value Share by Application (2021-2032) Figure 19. Global Cancer Imaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cancer Imaging Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cancer Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cancer Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cancer Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cancer Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cancer Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cancer Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cancer Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cancer Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cancer Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cancer Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cancer Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • CT
  • MRI
  • MRA
  • Others
Applications
  • Clinical Routine
  • Clinical Trials
Companies covered
  • Imaris
  • Varian
  • DOSIsoft
  • Certis Oncology
  • MIM Software Inc.
  • Arterys
  • SIEMENS
  • Brainomix
  • Oncology Systems Limited
  • Mirada
  • GE HealthCare
  • Mint Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cancer Imaging Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cancer Imaging Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cancer Imaging Software Market Dynamics
  1. 2.1 Cancer Imaging Software Industry Trends
  2. 2.2 Cancer Imaging Software Industry Drivers
  3. 2.3 Cancer Imaging Software Industry Opportunities and Challenges
  4. 2.4 Cancer Imaging Software Industry Restraints
3 Cancer Imaging Software Market by Company
  1. 3.1 Global Cancer Imaging Software Company Revenue Ranking in 2025
  2. 3.2 Global Cancer Imaging Software Revenue by Company (2021-2026)
  3. 3.3 Global Cancer Imaging Software Company Ranking (2024-2026)
  4. 3.4 Global Cancer Imaging Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Cancer Imaging Software Company Product Type and Application
  6. 3.6 Global Cancer Imaging Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cancer Imaging Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cancer Imaging Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cancer Imaging Software Market by Type
  1. 4.1 Cancer Imaging Software Type Introduction
  2. 4.1.1 CT
  3. 4.1.2 MRI
  4. 4.1.3 MRA
  5. 4.1.4 Others
  6. 4.2 Global Cancer Imaging Software Sales Value by Type
  7. 4.2.1 Global Cancer Imaging Software Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cancer Imaging Software Sales Value by Type (2021-2032)
  9. 4.2.3 Global Cancer Imaging Software Sales Value Share by Type (2021-2032)
5 Cancer Imaging Software Market by Application
  1. 5.1 Cancer Imaging Software Application Introduction
  2. 5.1.1 Clinical Routine
  3. 5.1.2 Clinical Trials
  4. 5.2 Global Cancer Imaging Software Sales Value by Application
  5. 5.2.1 Global Cancer Imaging Software Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cancer Imaging Software Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cancer Imaging Software Sales Value Share by Application (2021-2032)
6 Cancer Imaging Software Regional Value Analysis
  1. 6.1 Global Cancer Imaging Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cancer Imaging Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cancer Imaging Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cancer Imaging Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cancer Imaging Software Sales Value (2021-2032)
  7. 6.3.2 North America Cancer Imaging Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cancer Imaging Software Sales Value (2021-2032)
  10. 6.4.2 Europe Cancer Imaging Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cancer Imaging Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cancer Imaging Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cancer Imaging Software Sales Value (2021-2032)
  16. 6.6.2 South America Cancer Imaging Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cancer Imaging Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cancer Imaging Software Sales Value Share by Country, 2025 VS 2032
7 Cancer Imaging Software Country-level Value Analysis
  1. 7.1 Global Cancer Imaging Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cancer Imaging Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cancer Imaging Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cancer Imaging Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cancer Imaging Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cancer Imaging Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cancer Imaging Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Imaris
  2. 8.1.1 Imaris Company Information
  3. 8.1.2 Imaris Business Overview
  4. 8.1.3 Imaris Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Imaris Cancer Imaging Software Product Portfolio
  6. 8.1.5 Imaris Recent Developments
  7. 8.2 Varian
  8. 8.2.1 Varian Company Information
  9. 8.2.2 Varian Business Overview
  10. 8.2.3 Varian Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Varian Cancer Imaging Software Product Portfolio
  12. 8.2.5 Varian Recent Developments
  13. 8.3 DOSIsoft
  14. 8.3.1 DOSIsoft Company Information
  15. 8.3.2 DOSIsoft Business Overview
  16. 8.3.3 DOSIsoft Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DOSIsoft Cancer Imaging Software Product Portfolio
  18. 8.3.5 DOSIsoft Recent Developments
  19. 8.4 Certis Oncology
  20. 8.4.1 Certis Oncology Company Information
  21. 8.4.2 Certis Oncology Business Overview
  22. 8.4.3 Certis Oncology Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Certis Oncology Cancer Imaging Software Product Portfolio
  24. 8.4.5 Certis Oncology Recent Developments
  25. 8.5 MIM Software Inc.
  26. 8.5.1 MIM Software Inc. Company Information
  27. 8.5.2 MIM Software Inc. Business Overview
  28. 8.5.3 MIM Software Inc. Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MIM Software Inc. Cancer Imaging Software Product Portfolio
  30. 8.5.5 MIM Software Inc. Recent Developments
  31. 8.6 Arterys
  32. 8.6.1 Arterys Company Information
  33. 8.6.2 Arterys Business Overview
  34. 8.6.3 Arterys Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Arterys Cancer Imaging Software Product Portfolio
  36. 8.6.5 Arterys Recent Developments
  37. 8.7 SIEMENS
  38. 8.7.1 SIEMENS Company Information
  39. 8.7.2 SIEMENS Business Overview
  40. 8.7.3 SIEMENS Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SIEMENS Cancer Imaging Software Product Portfolio
  42. 8.7.5 SIEMENS Recent Developments
  43. 8.8 Brainomix
  44. 8.8.1 Brainomix Company Information
  45. 8.8.2 Brainomix Business Overview
  46. 8.8.3 Brainomix Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Brainomix Cancer Imaging Software Product Portfolio
  48. 8.8.5 Brainomix Recent Developments
  49. 8.9 Oncology Systems Limited
  50. 8.9.1 Oncology Systems Limited Company Information
  51. 8.9.2 Oncology Systems Limited Business Overview
  52. 8.9.3 Oncology Systems Limited Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Oncology Systems Limited Cancer Imaging Software Product Portfolio
  54. 8.9.5 Oncology Systems Limited Recent Developments
  55. 8.10 Mirada
  56. 8.10.1 Mirada Company Information
  57. 8.10.2 Mirada Business Overview
  58. 8.10.3 Mirada Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mirada Cancer Imaging Software Product Portfolio
  60. 8.10.5 Mirada Recent Developments
  61. 8.11 GE HealthCare
  62. 8.11.1 GE HealthCare Company Information
  63. 8.11.2 GE HealthCare Business Overview
  64. 8.11.3 GE HealthCare Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GE HealthCare Cancer Imaging Software Product Portfolio
  66. 8.11.5 GE HealthCare Recent Developments
  67. 8.12 Mint Medical
  68. 8.12.1 Mint Medical Company Information
  69. 8.12.2 Mint Medical Business Overview
  70. 8.12.3 Mint Medical Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mint Medical Cancer Imaging Software Product Portfolio
  72. 8.12.5 Mint Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst